ANIX

SEC Filing Summary: CopyTele, Inc. (10-Q)

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended January 31, 2001, for CopyTele, Inc. (Note: The input metadata referenced "Anixa Biosciences," but the filing text explicitly identifies the registrant as CopyTele, Inc.). The company is classified as a Development Stage Enterprise since its inception in November 1982. Its principal activities involve the development, production, and marketing of hardware-based digital encryption products (USS-900, DSS-1000, ULP-1) and research into flat-panel display technologies.

Key Financial Metrics

Liquidity & Debt: The company has no long-term debt listed on the balance sheet. Current liabilities total $1,269,157, primarily accounts payable ($1,045,298). Management has received representations from the CEO, President, and an outside director to provide short-term loans totaling up to $1.1 million if necessary to fund operations through January 31, 2002.

Material Changes vs. Prior Period

• Revenue Decline: Sales decreased by approximately 36% ($99,000) compared to the prior year quarter. However, sales of the flagship USS-900 product increased significantly to $153,000 (86% of total sales), offsetting declines in other areas.
• Margin Expansion: Gross profit increased to $104,041 (58% margin) from $69,727 (25% margin), driven by the higher mix of USS-900 sales.
• Expense Reduction: Selling, General, and Administrative (SG&A) expenses decreased by approximately 13% ($180,000) due to cost-cutting measures, specifically reductions in employee compensation ($92,000) and engineering supplies ($82,000).
• Cash Position: Cash and cash equivalents dropped from $1,134,045 at the end of the prior fiscal year (Oct 31, 2000) to $703,123 at Jan 31, 2001, reflecting a net cash burn of over $1 million in the quarter.

Outlook, Risks, and Contingencies

• Liquidity Risk: The company projects it can continue operations until at least the end of the first quarter of fiscal 2002 using existing cash and receivables, contingent on further expense reductions. There is no assurance of future profitability or ability to secure additional funding.
• Listing Requirements: To maintain its Nasdaq National Market listing, the company must maintain $4 million in net tangible assets (currently ~$5.03 million) and a minimum bid price of $1.00 per share. As of March 14, 2001, the stock price was $0.75, placing the company at risk of delisting if the price does not recover.
• Barter Transaction: In August 2000, the company exchanged $3 million of inventory for commercial trade credits (recorded as "Other Assets"). Management asserts these are properly valued, but their realization depends on future usage for advertising or services.
• Inventory Valuation: Inventory is recorded at net realizable value. Given limited sales history, there is a risk that inventory may need to be written down if selling prices must be reduced.

Investor Verification Checklist

• Stock Price Compliance: Verify if the stock price has recovered to $1.00 to avoid Nasdaq delisting proceedings.
• Barter Asset Realization: Confirm the actual utilization of the ~$2.95 million in commercial trade credits and their impact on future cash flow.
• Executive Loan Commitments: Monitor whether the represented $1.1 million in short-term loans from executives is drawn upon or if alternative financing is secured.
• Inventory Turnover: Assess if the $1.83 million inventory level is consistent with current sales velocity to rule out potential write-downs.
• Revenue Sustainability: Determine if the increase in USS-900 sales is sustainable or a one-time spike, given the overall 36% revenue decline.